Modeling the Effect of a Preventive Intervention on the Natural History of Cancer: Application to the Prostate Cancer Prevention Trial

Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

1998 • 5,487 citations

Risk Factors for Lung Cancer and for Intervention Effects in CARET, the Beta-Carotene and Retinol Efficacy Trial

1996 • 1,248 citations

Lead Times and Overdetection Due to Prostate-Specific Antigen Screening: Estimates From the European Randomized Study of Screening for Prostate Cancer

2003 • 1,066 citations

Operating Characteristics of Prostate-Specific Antigen in Men With an Initial PSA Level of 3.0 ng/mL or Lower

2005 • 677 citations

Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT)

2005 • 352 citations

Analysis of Doubly-Censored Survival Data, with Application to AIDS

1989 • 272 citations

ESTIMATION OF THE DURATION OF A PRE-CLINICAL DISEASE STATE USING SCREENING DATA

1983 • 263 citations

Simplified Models of Screening for Chronic Disease: Estimation Procedures from Mass Screening Programmes

1984 • 259 citations

The Influence of Finasteride on the Development of Prostate Cancer

2003 • 188 citations

Censoring in an Epidemic with an Application to Hemophilia-Associated AIDS

1989 • 158 citations

Screening Sensitivity and Sojourn Time From Breast Cancer Early Detection Clinical Trials: Mammograms and Physical Examinations

2001 • 131 citations

Some Pitfalls in the Evaluation of Screening Programs

1969 • 121 citations

Estimation of Tamoxifen's Efficacy for Preventing the Formation and Growth of Breast Tumors

2000 • 68 citations

SERIAL PROSTATE SPECIFIC ANTIGEN SCREENING FOR PROSTATE CANCER: A COMPUTER MODEL EVALUATES COMPETING STRATEGIES

1999 • 53 citations

Screening for the early detection of cancer— III. Estimation of disease natural history

1978 • 53 citations

Estimation and Prediction for Cancer Screening Models Using Deconvolution and Smoothing

2001 • 24 citations

ESTIMATING ASYMPTOMATIC DURATION IN CANCER: THE AIDS CONNECTION

1997 • 18 citations

Prevalence of Prostate Cancer Among Men With a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter

2004 • 16 citations